Uncategorized

STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today we regale you with mid-August delights from the EMA, ICER, and a federal appeals court.

Hope you had a lovely weekend. My kids went to Disneyland, an aquarium, and the beach — but now seem thrilled most of all by the television.

Continue to STAT+ to read the full story…

​Read More

Published

on

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today we regale you with mid-August delights from the EMA, ICER, and a federal appeals court.

Hope you had a lovely weekend. My kids went to Disneyland, an aquarium, and the beach — but now seem thrilled most of all by the television.

Continue to STAT+ to read the full story…

​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version